Suboxone and Ingrezza drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Suboxone (buprenorphine hydrochloride; naloxone hydrochloride) and Ingrezza (valbenazine tosylate). Common drug interactions include gastrointestinal disorder among females and parkinsonism among males.

The phase IV clinical study analyzes what interactions people have when they take Suboxone and Ingrezza. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Suboxone?

Suboxone has active ingredients of buprenorphine hydrochloride; naloxone hydrochloride. It is often used in opiate withdrawal. eHealthMe is studying from 31,249 Suboxone users. Check the latest studies of Suboxone.

What is Ingrezza?

Ingrezza has active ingredients of valbenazine tosylate. eHealthMe is studying from 23,666 Ingrezza users. Check the latest studies of Ingrezza.

On Jul, 10, 2026

14 people who take Suboxone and Ingrezza together, and have interactions are studied.

Suboxone and Ingrezza drug interactions.

What are the common drug interactions of Suboxone and Ingrezza, by gender? *:

female:

Gastrointestinal disorder (functional problems of gastrointestinal tract)
Procedural pain
Vomiting
Withdrawal syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance)
Disturbance in attention
Dizziness
Orthostatic hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)
Asthenia (weakness)
Blood pressure increased
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)

male:

Parkinsonism (degenerative disorder of the central nervous system characterized by tremor and impaired muscular coordination)
Somnambulism (sleep walking)
Drooling (drop saliva uncontrollably from the mouth)

What are the common drug interactions of Suboxone and Ingrezza, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Drooling (drop saliva uncontrollably from the mouth)

50-59:

Procedural pain
Vomiting
Parkinsonism (degenerative disorder of the central nervous system characterized by tremor and impaired muscular coordination)
Somnambulism (sleep walking)
Asthenia (weakness)
Blood pressure increased
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Dental care

60+:

Disturbance in attention
Dizziness
Orthostatic hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)
Withdrawal syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance)

What are the existing conditions these people have? *

Tardive Dyskinesia (a disorder that involves involuntary movements): 10 people, 71.43%
Stress And Anxiety: 2 people, 14.29%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 2 people, 14.29%
Parkinson's Disease: 2 people, 14.29%
Pain: 2 people, 14.29%
Muscle Spasms (muscle contraction): 2 people, 14.29%
Neuropathy Peripheral (surface nerve damage): 1 person, 7.14%
Insomnia (sleeplessness): 1 person, 7.14%
High Blood Cholesterol: 1 person, 7.14%
Drug Abuse: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Suboxone and Ingrezza?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously